Jim Cramer’s Charitable Trust plans Dover trim and Johnson & Johnson purchase

Jim Cramer’s Charitable Trust trades are set to shift away from Dover and toward Johnson & Johnson, according to a CNBC Investing Club alert. The trust said it would sell 90 Dover shares at about $204 and buy 60 Johnson & Johnson shares at about $253, a planned portfolio change rather than independently verified completed transactions.

For investors following the alert, the key distinction is between the two announced trades and the separate names the trust said it was watching. CNBC said the trust was looking to add Intel once it was no longer restricted from trading Intel, and was eyeing Corning after raising its rating on the company to a buy-equivalent “1.”

What is Jim Cramer’s Charitable Trust buying and selling?

• Dover: The trust said it would sell 90 shares. Its holding would fall to 195 shares, or about 1% of the portfolio, from roughly 1.5%.

• Johnson & Johnson: The trust said it would buy 60 shares. Its position would rise to 400 shares, or about 2.55% of the portfolio, from 2.15%.

• Intel and Corning: Neither was included in the announced transaction. The trust said it wanted to add Intel after its trading restriction ended and was considering Corning.

CNBC said the trust’s decision to reduce Dover followed what it described as a mixed quarter. Dover encountered a problem increasing production in its carbon-dioxide refrigeration operation while it consolidated manufacturing sites, according to the alert. The trust called the issue fixable, but said it chose to reduce the position after the stock recovered from its July 23 decline, when shares closed near $198.

The planned Dover sale was expected to produce an average gain of about 10% on shares acquired in late 2024, CNBC reported. A portfolio weighting is the portion of a portfolio represented by one investment, so the sale would reduce Dover’s influence on the trust’s overall results.

Johnson & Johnson had declined from the high $260s in early July to around $252 on Monday, CNBC said. The trust described the pullback as an opportunity to add shares. It also said the company’s lower full-year outlook, which reflected two acquisitions, was an accounting adjustment associated with completing deals rather than a substantive change to the outlook.

The Intel interest follows a prior purchase. In a July 27 alert, CNBC said the trust bought 100 Intel shares at roughly $93.84, bringing its position to 1,200 shares and 2.85% of the portfolio. The trust cited Intel’s better-than-expected second-quarter results and said it viewed a subsequent share-price drop amid a broader semiconductor sell-off as an opportunity.

CNBC’s alert disclosed that the trust was long Dover, Johnson & Johnson, Intel and Corning. It also said subscribers receive alerts before trust transactions, with Cramer generally waiting 45 minutes after an alert to trade, or 72 hours if he discussed the stock on CNBC television. CNBC said no specific outcome or profit is guaranteed.

This story draws on original reporting from CNBC.